Herceptin

This page contains recent news articles, when available, and an overview of Herceptin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

BCAC responds to issues in Herceptin debate  -  11 Aug 2008
In 2007 PHARMAC applied to MedSafe, the government’s expert medicines safety and regulatory body, to have nine weeks of Herceptin approved for use in New Scoop.co.nz (press release),

Herceptin and Road Safety Trials  -  11 Aug 2008
The judiciousness of Pharmacs decisions in relation to herceptin provision was challenged, yet Pharmac has parameters set around the decisions it may make, Scoop.co.nz (press release),

Breast cancer patients still denied free cure  -  11 Aug 2008
Women suffering from breast cancer and prescribed Herceptin by their doctors are still waiting for the government to honour its promise to include the drug Malta Today,

On promises …  -  11 Aug 2008
...commitments such as the PM’s declared intention to put medications like the breast cancer fighting drug Herceptin on the list of free health services. Malta Today,

Bolton cancer patients fare well in 'postcode lottery'  -  11 Aug 2008
...care trusts (PCTs) since October, 2006, in response to requests by patients for “exceptional drugs�?, including treatments like Herceptin and Sutent. The Bolton News,

New research finds way to switch off breast cancer and leukaemia  -  11 Aug 2008
...known as Gab2, plays a part in the development of breast cancer along with the major breast cancer oncogene, HER2, the target of the drug Herceptin. News-Medical.net,

Should Pharmac extend Herceptin funding from nine weeks to 12 months?  -  Aug 7, 2008
Pharmac's review of Herceptin's most appropriate course length has "failed to convince us that 12-month treatments offer any additional benefits over the New Zealand Herald,

Tapu Misa: Hope a drug with odd side-effects  -  Aug 10, 2008
If you saw coverage last week of Pharmac's decision not to fund the 12-month course of Herceptin, you might be forgiven for thinking that this was a New Zealand Herald,

Herceptin: The debate  -  Aug 7, 2008
Panorama said indications Herceptin was not just another drug came in 2005 at the American Society of Clinical Oncology conference, where the latest Stuff.co.nz,

Editorial: Pharmac drug decision is a pill that must be swallowed  -  Aug 9, 2008
The agency had been ordered to reconsider the matter after a group of women, dubbed the "Herceptin Heroines", took legal action alleging it had not New Zealand Herald,

Matthew Brougham: Nine-week promise  -  Aug 9, 2008
By Matthew Brougham Matthew Brougham is not convinced of extra benefits from a 12-month course of Herceptin. Photo / Mark Mitchell Should Pharmac extend New Zealand Herald,

Herceptin decision a blow, but not for politicians to make  -  Aug 7, 2008
Pharmac's decision to turn down additional funding to extend Herceptin funding from 9 weeks to 12 months is a bitter blow for many New Zealand women, Scoop.co.nz (press release),

Nats urge funding for 12-month Herceptin programme  -  Jul 30, 2008
By SALLY FRENCH - Stuff.co.nz | Thursday, 31 July 2008 The National Party is urging the Government to free up money to fund 12 months of Herceptin. Stuff.co.nz,

Herceptin Decision Saves Money, Not Lives  -  Aug 7, 2008
..."The 12-month course of Herceptin is already funded in 33 countries around the world - such decisions are always financially motivated. Scoop.co.nz (press release),

Kerre Woodham: Battle weary over funding  -  Aug 9, 2008
After a couple of years of submissions, petitions and rallies failed to sway Pharmac, the so-called Herceptin Heroines took Pharmac to court. New Zealand Herald,

Herceptin decision disappoints GP Campaigning GP Sue Walthert ...  -  Aug 6, 2008
Campaigning GP Sue Walthert is disappointed, but not much surprised, by today’s decision by Pharmac not to fund a year of Herceptin for women with early New Zealand Doctor Online,

EDITORIAL: Herceptin must get more funding  -  Aug 4, 2008
A decision is imminent on whether the Government medicine-funding agency Pharmac will extend its provision for the cancer drug Herceptin. MyTown Bay of Plenty,

Weekend to End Breast Cancer a chance to give back  -  Aug 7, 2008
Her cancer went into remission after courses of chemotherapy and treatment with the drug Herceptin. "That is the reason I am doing the walk. Edmonton Sun,

Running for a cure for cancer  -  Aug 7, 2008
By Tamara Botting, the Gazette Stormy weather may have delayed Laura McCutcheon's fifth annual garage sale to raise funds for the Weekend to End Breast Grand River Sachem,

'Guardian angel' helped woman find lump  -  Aug 8, 2008
She points out her own medicine -- Herceptin -- costs about $2500 per treatment in provinces where the drug is not covered. Edmonton Journal,

Mom of three youngsters needs no training for weekend walk  -  Aug 8, 2008
By Debra Downey While most participants might be pounding the pavement on a regular training regimen to prepare for the Weekend to End Breast Cancer, Dundas Star,

Oshawa woman says charity walk is “least she can do�? for breast ...  -  Aug 8, 2008
By Moya Dillon OSHAWA -- Until a close friend was diagnosed with breast cancer, Melody Geurts had never really thought about the disease. Newsdurhamregion.com,

Cancer survivors sad for other women  -  Aug 7, 2008
By Jessica Wauchop The refusal by Government agency Pharmac to fund a 12-month course of Herceptin for women with HER2 breast cancer is hard to accept for Gisborne Herald,

I ignored a lump because I believed breastfeeding made me safe ...  -  Aug 9, 2008
It meant she also needed chemotherapy - eight doses over four months - and was then prescribed the drug Herceptin for a year. Herceptin works by attaching Daily Mail,

Cancer sufferer `gutted' over Pharmac ruling  -  Aug 8, 2008
..."I have borrowed as much money as I can from friends and whanau, so I will keep fundraising and just take one session of Herceptin at a time. Waikato Times,

Cyclacel Publishes Study of Seliciclib Synergy with Tarceva and ...  -  Jul 14, 2008
In vitro, the combination of seliciclib and Herceptin resulted in greater loss of cyclin D1 and increased down-regulation of HER2 than either compound Business Wire (press release),

Cutting Edge Information's Research on Monoclonal Antibodies ...  -  Jul 30, 2008
Successful brands such as Rituxan, Herceptin and Erbitux are all expected to grow by anywhere from 23% to 80% by 2013. Furthermore, there are several MarketWatch

Herceptin Vials To Be Checked for Damage, FDA Warns  -  Jul 14, 2008
July 14, 2008 — An increased number of complaints have been received regarding damaged and broken vials of trastuzumab injection 440 mg (Herceptin, Medscape (subscription)

The new cancer trial that offers hope to thousands  -  Aug 9, 2008
In 2005 ex-nurse Barbara Clark fought such a strong campaign to be prescribed the breast cancer treatment Herceptin that then Health Secretary Patricia guardian.co.uk,

Targeted Medicine: Health Care's Next Big Thing  -  Aug 1, 2008
Perhaps the most famous of all targeted therapeutics is Genentech's (NYSE: DNA) Herceptin, which inhibits the HER2 receptor. Unfortunately there are some Motley Fool

Taxpayers want disciplined spending  -  Aug 7, 2008
..."Labour must seriously be questioning its own priorities when it can't fund Herceptin, but can afford to give ACC staff publicly funded manicures and botox Scoop.co.nz (press release),

Cancer patients in a bind over drugs  -  Aug 6, 2008
CancerCare Manitoba has a $29-million budget to administer intravenous cancer drugs like Herceptin this year. Dhaliwal said cancer specialists across Canada Winnipeg Free Press,

Running For Life  -  Aug 5, 2008
However, Leanne was informed by her medical team that her recovery depended on her being able to access the latest new drug on the market, Herceptin, Grenfell Record and Bland Advertiser,

A JOURNEY WITH BREAST CANCER  -  Jul 29, 2008
Surgery was scheduled immediately, followed by chemotherapy and Herceptin, a drug that specifically targets HER2-positive cancer cells. North American Press Syndicate,

ARIAD Announces Start of Phase 2 Clinical Trial of Oral ...  -  Jul 30, 2008
The multi-center, single-arm, Phase 2 study will evaluate oral deforolimus in combination with intravenous trastuzumab (Herceptin(R)) in patients with MarketWatch

Roche Seeks Bargain as Genentech Investors Want More (Update2)  -  Jul 22, 2008
...is offering $43.7 billion for total control of Genentech Inc. to squeeze more profits from the companies' Avastin and Herceptin cancer drugs. Bloomberg

DHB's response to PHARMAC’s decision  -  Aug 6, 2008
...compelling information, we accept PHARMAC’s position that there is no current basis to support funding for 12 month treatments with Herceptin. Scoop.co.nz (press release),

FDA Releases List of Genomic Biomarkers Predictive of Drug ...  -  Aug 1, 2008
Another drug for which testing is required is trastuzumab (Herceptin, Genentech). Herceptin is a monoclonal antibody that binds strongly and selectively to Medscape (subscription)

Ariad Starts Phase II Study for Breast Cancer  -  Aug 5, 2008
The multicenter, single-arm study will evaluate the drug in combination with IV trastuzumab (Herceptin) in 33 patients with metastatic, HER2-positive breast FDA news (subscription),

Glaxo Tries Fixed-Price For Cancer Med In UK  -  Aug 4, 2008
Glaxo estimates this would benefit about 70 per cent of those in the UK who fail other cancer treatments including Herceptin. Pharmalot,

'Her strength motivated us'  -  Aug 10, 2008
She made the long journey during yesterday's heat wave to raise funds for the drug Herceptin, which she takes to fight off a relapse, as well as to raise Edmonton Sun,

SUVs, CEOs and WCs  -  Jul 31, 2008
Prescribing information: The initial clinical data on Herceptin made the product look like a failure. Only later, when a diagnostic test revealed that it Medical Marketing and Media,

Genentech Needs More Profit Power  -  Jul 15, 2008
...(That disparity made comparisons between the two periods tough for Herceptin.) Genentech's in-house Avastin sales now account for 20% of its revenue, Motley Fool

ARIAD Announces Start of Phase 2 Clinical Trial of Oral ...  -  Aug 5, 2008
The multi-center, single-arm, Phase 2 study will evaluate oral deforolimus in combination with intravenous trastuzumab (Herceptin(R)) in patients with ADMET.net (press release),

Notable movers  -  Jul 22, 2008
...offered to buy the rest of Genentech for $89 a share to increase its share of profit from the best-selling Avastin and Herceptin tumor medicines. San Jose Mercury News,

Cancer Cures Find Biology-Physics Convergence With MIT `Genius'  -  Aug 6, 2008
MIT biologists were involved in the original gene discoveries that led to the cancer drug Herceptin, made by South San Francisco-based Genentech Inc., Bloomberg

First step towards switching off breast cancer, leukaemia  -  Aug 9, 2008
The molecule, known as Gab2, operates downstream of a major breast cancer oncogene, HER2, the target of the drug Herceptin. A research team from the Garvan Hindu,

Monogram Announces 2008 Second Quarter Financial Results  -  Jul 29, 2008
Physicians currently use these semi-quantitative technologies to determine HER2 status and decide whether or not to prescribe Herceptin(R). MarketWatch

Doctor tells of own cancer battle  -  Jul 16, 2008
But Mrs Walthert's struggle continues, with surgery looming and treatment with the controversial herceptin. "My stage is still a bit of a chaotic stage. Southland Times,

Immunogen's Wild Swings Due to Lack of Information at ASCO  -  Jul 14, 2008
One of these trials will evaluate T-DM1 in Herceptin resistant breast cancer patients, similarl to the ongoing phase II trial. One big difference in the new Seeking Alpha,

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.